Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus: A Cardiologist’s View ( Coronary Artery Bypass Graft Surgery )

Publication series : Coronary Artery Bypass Graft Surgery

Author: Bezdenezhnykh Natalia Alexandrovna Sumin Alexei NikolaevichBezdenezhnykh Andrey Viktorovich and Barbarash OlgaLeonidovna  

Publisher: IntechOpen‎

Publication year: 2017

E-ISBN: INT6802770416

P-ISBN(Paperback): 9789535137092

P-ISBN(Hardback):  9789535137108

Subject: R6 Surgery

Keyword: 外科学

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus: A Cardiologist’s View

Description

The review presents current data on the prevalence of diabetes in the cohort of patients undergoing coronary artery bypass grafting. The relevance of active approach to the identification of diabetes and prediabetes in patients with coronary artery disease (CAD) before coronary revascularization is reviewed. Recent information about the negative impact of diabetes on the prognosis of myocardial revascularization is reported as well as the main mechanisms responsible to the development of adverse outcomes of interventions in these patients. Target perioperative values of glycemia recommended by the leading associations of the study of diabetes have been compared. Beneficial potential of other carbohydrate metabolism markers (glycated hemoglobin, fructosamine, 1,5-anhydroglucitol) in patients with diabetes mellitus (DM) in terms of their impact on cardiovascular prognosis, including coronary intervention. The results of studies comparing different management strategies for these patients are reviewed. The significance of carbohydrate metabolism compensation during myocardial revascularization is reported; thus, a too stringent glycemic control has no benefits neither for percutaneous nor for open coronary intervention. Recent trials suggest the groups of antidiabetic drugs and evidence of their impact on the cardiovascular system. The importance of comprehensive monitoring of major risk factors in diabetic patients with coronary intervention has been proved.

The users who browse this book also browse